Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Card image cap
Barcelona, Spain; 1-3 October 2015 Further information

Free Communications

Endocrine Oncology/Turner

Resveratrol Potentiates Growth Inhibitory Effects of Rapamycin in PTEN-deficient Lipoma Cells by Suppressing p70S6 Kinase Activity
aCenter for Pediatric Research Leipzig (CPL), Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany; bLeipzig University Medical Center, IFB Adiposity Diseases Leipzig, Leipzig, Germany
MEN1 Syndrome Because of Combined Germline and Somatic Mosaicism, with Important Consequences for Relatives
aRadboud University Medical Center, Nijmegen, The Netherlands; bUniversity Medical Center Utrecht, Utrecht, The Netherlands
Screening in Children with Succinate Dehydrogenase B (SDHB) Mutations: a Single Centre's Family Clinic Experience
Barts and the London School of Medicine and Dentistry, William Harvey Research Institute, Centre for Endocrinology, Queen Mary University of London, London, UK
X Chromosome Gene Dosage and the Risk of Developing Congenital and Acquired Traits in Turner Syndrome: a Cross-Sectional Database Analysis of the French National Rare Disease Network
aPaediatric Endocrinology and Diabetology Department, Robert Debre Hospital, Assistance Publique Hôpitaux de Paris, Reference Center for Rare Endocrine Diseases of Growth, Université Paris-Diderot, Paris, France; bClinical Epidemiology Unit, Robert Debre Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Diderot, Paris, France; cFrench Turner Syndrome Study Group, France, France
Hereditary Turner Syndrome 46,X,rec(X)inv(p21q28) in Six Women and Four Generations: Estimation of Skeletal Effects of GH Treatment
aDepartment of Paediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic; bGennet, Prague, Czech Republic